ArticleCancers2023

Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with 'Actionable' Pulmonary Nodules.

Claire Auger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.